National Institutes of Health logo
NIH Exploratory/Developmental Grants Phase II (R33)

Enhancing Mechanistic Research on Precision Probiotic Therapies (R33)

Funds mechanistic work on the host biology that decides who responds to a probiotic and who does not.

OpenNational Institutes of HealthUnited States

Probiotic trials produce inconsistent results, and the usual explanation is that people differ. This notice funds turning that explanation into something measurable.

The goal is precision probiotic therapy: characterising person-specific features that affect probiotic response, so responders can be identified as a subgroup rather than discovered afterwards.

The host features named are wide and c…

Rigorously designed mechanistic studies, in animal models or human subjects, characterising person-specific host features — native microbiome, immune system, gender, diet, age, genetic background, lifestyle and health history — that affect probiotic response, to identify responder subgroups and address the heterogeneity causing inconsistent probiotic outcomes. Clinical trials are optional.

CycleiHow often this grant runs - e.g. annually, on a rolling basis, or a one-off call.Multiple per year
Next deadlineiThe next date applications are due. Rolling means you can apply any time.2 Jun 2027
Decision timeiTypical time from the deadline to the funder's decision.26 weeks
Project durationiHow long the funded work is expected to run.-
Award typeiThe form of funding - grant, equity, loan, tax credit, etc.Grant
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.-
Funding pooliThe total budget available across all awards in this round.-

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see how to apply

Sign up free to see what you submit

Sign up free to see how they score you

Sign up free to see the timeline

Sign up free to see where teams trip up

Guides for this application

All guides →
National Institutes of Health logo
Between cycles

Advanced Development of Informatics Technologies for Cancer Research and Management

NIH · United States

Funds the enhancement of a cancer informatics tool that has cleared prototyping, shows real promise, and has not yet been widely adopted.

AIBiotech
$50K – $600K
National Institutes of Health logo
Closed

Community Engagement Evaluation and Data Coordination (CEED) Hub to Advance Data and Practice Transformation for Optimizing Oral Health for All

🇺🇸NIH · United States

Funds a single hub that coordinates data, evaluation and operations for a consortium of community-based oral health research projects.

National Institutes of Health logo
Between cycles

Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03)

🇺🇸NIH · United States

Funds one small self-contained project for a scholar already inside the Clinical and Translational Science Award network, on the way to a first full award.

$50K
National Institutes of Health logo
Closed

Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI)

NIH · United States

Funds the move of an imaging-centred multimodal AI tool from a trained and tested prototype towards real clinical use, as regulated device software.

AIMedtech
National Institutes of Health logo
Closed

PRIMED-AI: Data-to-Model Academic-Industrial Partnerships (D2M-AIP) for Precision Medicine with AI: Integrating Imaging with Multimodal Data

NIH · United States

Funds a company and an academic team to build and test an imaging-centred multimodal AI decision tool, developed as software that is a medical device.

AIMedtech
National Institutes of Health logo
Between cycles

Sustained Support for Informatics Technologies for Cancer Research and Management

NIH · United States

Funds the running costs and continued relevance of a cancer informatics tool that researchers already depend on.

AIBiotech
$50K – $600K